8-K//Current report
Acrivon Therapeutics, Inc. 8-K
Accession 0000950170-25-071385
$ACRVCIK 0001781174operating
Filed
May 13, 8:00 PM ET
Accepted
May 14, 4:10 PM ET
Size
397.0 KB
Accession
0000950170-25-071385
Documents
- 8-Kacrv-20250514.htmPrimary
8-K
- EX-99.1acrv-ex99_1.htm
EX-99.1
- GRAPHICimg28311487_0.jpg
GRAPHIC
- EX-101.SCHacrv-20250514.xsd
XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0000950170-25-071385-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLacrv-20250514_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Acrivon Therapeutics, Inc.
CIK 0001781174
Entity typeoperating
Related Parties
1- filerCIK 0001781174
Filing Metadata
- Form type
- 8-K
- Filed
- May 13, 8:00 PM ET
- Accepted
- May 14, 4:10 PM ET
- Size
- 397.0 KB